University of Virginia
I am currently a Research Associate at University of Virginia Health System. After receiving my medical degree from Dalian Medical University in China, I began to study the molecular and pathophysiological mechanisms of metabolic disorders at Peking University Health Science Center and received my Ph.D. in 2013. After graduation, I continued my postdoctoral research at AstraZeneca-Shenzhen University Joint Institute of Nephrology and initiated my own research on the metabolic nephropathy. I was well funded by the National Natural Science Foundation of China (Young Scientists Fund) and China Postdoctoral Science Foundation as an independent principal investigator. Since 2016, I have joined the Division of Endocrinology and Metabolism at University of Virginia Health System. In capacity of a Research Associate, I currently focus on insulin?s metabolic and vasculature actions. I have authored a total of nine peer-reviewed articles in top-quality journals, including PNAS, Biochim Biophys Acta and Journal of Diabes. Now I am serving as an editorial board member for Journal of Clinical and Molecular Endocrinology as well as a reviewer board member for Journal of Vascular Medicine & Surgery, International Journal of Molecular Sciences and Biomedical Journal of Scientific & Technical Research.
Insulin?s action and its regulation in health and insulin resistant states, especially the regulation of insulin?s action in the vasculature and its relation to insulin?s metabolic action and the cardiovascular complications of diabetes.
? Physiological and pathophysiological roles of prostaglandin membrane-associated receptors and nuclear receptors in renal, hepatic, and cardiovascular systems.